0%
PulzCAD™
PulzCAD™ is a next-generation 2-lead wearable ECG device for cardiac stress testing that provides advanced AI-driven analytics that aid Cardiologists in diagnosing CAD with much higher sensitivity compared to traditional cardiac stress testing technology.
18 million people die of heart attack each year globally
Worsening problem with changes in lifestyle, diet, and stress factors
No easy-to-use and sufficiently accurate ECG solutions to diagnose CAD early
Traditional ECG based stress testing uses outdated and grandfathered 50+ year old technology and concepts to identify changes in ECG patterns arising from stress-induced ischemia.
Unreliable, inaccurate and inconsistent in detecting CAD
Low sensitivity leads to high number of false negatives leading to potentially fatal missed diagnoses
Bulky and cumbersome using 12-lead systems tethered to machine
PulzCAD™ enables exceptional diagnostic accuracy exhibiting ~85-90%sensitivity and ~75-85% specificity in early blinded clinical investigations, when compared to gold standard of percutaneous coronary angiogram results*.
Our innovative patented cloud-based algorithms processes the high-resolution ECG data collected by the PulzCAD™ device during a stress test session. And within 5 mins of the session completion, the system presents a PulzCAD™ Score alongside advanced ECG feature charts that a cardiologists can assess to derive a more accurate CAD diagnosis.
Compact chest-wearable ECG device the size of a small matchbox collects high-resolution ECG data from just two leads to provide the unmatched accuracy in diagnosis.
Our AI-driven signal analytics and motion compensation algorithms extracts unique features even from the noisiest signals and offers unique ways to visualize individual ECG beats isolated at every heart-rate during the stress testing session.
Cardiologists can now review both the live ECG snapshots and the advanced PulzCAD reports containing ECG feature charts from anywhere right after a session.
PulzCAD™ is now commercially available in India where CDSCO approved medical devices can be commercially marketed for use in hospitals and clinics.
What exactly is PulzCAD™?
The PulzCAD™ device is a next-gen wearable Cardiac Stress Testing system that comprises of 3 distinct components: i. a compact chest-wearable unit for acquiring 2-channels of high-resolution ECG data, ii. a mobile/tablet application to conduct the cardiac stress test and view the live ECG and HR in real-time during the stress test, iii. and a cloud computing portal that runs our proprietary algorithms on the stress ECG data and generates a final report.
How Does PulzCAD™ provide superior results compared to the current technology?
PulzCAD™ uses proprietary patented algorithms that leverage advanced signal processing and AI analytics to cleanly extract ECG features from highly noisy ambulatory ECG signals during a stress test and generate human readable and interpretable features along with a final PulzCAD™ score that Cardiologists can review and assess to estimate the likelihood of ischemic CAD in patients.
Does the PulzCAD™ device automatically generate a CAD diagnosis?
The PulzCAD™ systems provides advanced stress ECG analysis in the form of ECG feature hysteresis charts along with a final PulzCAD™ Score that estimates the likelihood of presence or absence of ischemic CAD as a guidance. The Cardiologist can use these advanced insights while also assessing various other patient risk factors before making the final diagnosis.
Is this product clinically validated?
We recently concluded a 3+ years long clinical investigation at Medanta Medicity where the final 14 months of this study was spent in obtaining and analyzing double blinded dataset from patients who underwent a regular cardiac ECG stress test along with coronary angiogram or Cardiac CT, while we simultaneously and independently collected stress ECG data using the PulzCAD™ device from these patients. Insights derived during these investigations were used to derive a unique scoring mechanism that cardiologists can apply in their diagnosis. We are collaborating with other institutions in India to expand this study as a multi-center on-going trial.
Can I buy this product as a direct consumer?
No. PulzCAD™ is a CDSCO-approved class 2 medical device that is currently available only to hospitals, clinics, and healthcare providers within India. If you are interested in being an early tester for a consumer version of this product that may become available in the future, please contact us.
How can my hospital/clinic get access to PulzCAD™?
Currently, PulzCAD™ is available to a select group of cardiologists and hospitals who have signed up to our early-access program. Please reach out to us contact@pulz.ai if you are interested in being part of this early access program.
